J Korean Neurosurg Soc.  2014 Oct;56(4):289-294. 10.3340/jkns.2014.56.4.289.

Clinical Characteristics of Cerebral Venous Thrombosis in a Single Center in Korea

• Park DS
• Moon CT
• Chun YI
• Koh YC
• Kim HY
• Roh HG

• KMID: 2018078
• DOI: http://doi.org/10.3340/jkns.2014.56.4.289

Abstract

OBJECTIVE
The purpose of this study is to investigate the clinical characteristics of cerebral venous thrombosis (CVT) in a single center in Korea.
METHODS
A total of 36 patients were diagnosed with CVT from August 2005 to May 2013. The patient data regarding age, sex, disease stage, pathogenesis, location, laboratory findings, radiological findings, and treatment modalities were retrospectively collected. The results were compared with those of previous studies in other countries.
RESULTS
The patient group comprised 21 men and 15 women with a mean age of 46.9 years (ranging from three months to 77 years). The most common cause was a prothrombotic condition (8 patients, 22.2%). Within the patient group, 13 patients (36.1%) had a hemorrhagic infarction, whereas 23 (63.9%) had a venous infarction without hemorrhage. By location, the incidence of hemorrhagic infarction was the highest in the group with a transverse and/or sigmoid sinus thrombosis (n=9); however, the proportion of hemorrhagic infarction was higher in the cortical venous thrombosis group (75%) and the deep venous thrombosis group (100%). By pathogenesis, the incidence of hemorrhagic infarction was the highest in the prothrombotic group (n=6), which was statistically significant (p=0.016).
CONCLUSION
According to this study, CVT was more prevalent in men, and the peak age group comprised patients in the sixth decade. The most common cause was a prothrombotic condition. This finding was comparable with reports from Europe or America, in which CVT was more common in younger women. Hemorrhagic infarction was more common in the prothrombotic group (p=0.016) than in the non-prothrombotic group in this study.

Keyword

Cerebral venous thrombosis; Hemorrhagic infarction; Prothrombotic condition

MeSH Terms

Americas
Colon, Sigmoid
Europe
Female
Hemorrhage
Humans
Incidence
Infarction
Korea
Male
Retrospective Studies
Sinus Thrombosis, Intracranial
Venous Thrombosis*

Reference

1. Bombeli T, Basic A, Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol. 2002; 70:126–132. PMID: 12111785.

2. Bousser MG, Chiras J, Bories J, Castaigne P. Cerebral venous thrombosis--a review of 38 cases. Stroke. 1985; 16:199–213. PMID: 3975957.

3. Bousser MG, Crassard I. Cerebral venous thrombosis, pregnancy and oral contraceptives. Thromb Res. 2012; 130(Suppl 1):S19–S22. PMID: 23026652.

4. Bousser MG, Ferro JM. Cerebral venous thrombosis : an update. Lancet Neurol. 2007; 6:162–170. PMID: 17239803.

5. de Freitas G, Bogousslavsky J. Risk factors of cerebral vein and sinus thrombosis. In : Caso V, Agnelli G, Paciaroni M, editors. Handbook on Cerebral Venous Thrombosis. Front Neurol Neurosci. Basel: Karger;2008. 23:p. 23–54.

6. Estanol B, Rodriguez A, Conte G, Aleman JM, Loyo M, Pizzuto J. Intracranial venous thrombosis in young women. Stroke. 1979; 10:680–684. PMID: 524408.

7. Ferro JM. Causes, predictors of death, and antithrombotic treatment in cerebral venous thrombosis. Clin Adv Hematol Oncol. 2006; 4:732–733. PMID: 17099629.

8. Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F. ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis : results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004; 35:664–670. PMID: 14976332.

9. Ferro JM, Crassard I, Coutinho JM, Canhão P, Barinagarrementeria F, Cucchiara B, et al. Decompressive surgery in cerebrovenous thrombosis : a multicenter registry and a systematic review of individual patient data. Stroke. 2011; 42:2825–2831. PMID: 21799156.

10. James AH, Bushnell CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol. 2005; 106:509–516. PMID: 16135580.

11. Keiper GL Jr, Sherman JD, Tomsick TA, Tew JM Jr. Dural sinus thrombosis and pseudotumor cerebri : unexpected complications of suboccipital craniotomy and translabyrinthine craniectomy. J Neurosurg. 1999; 91:192–197. PMID: 10433306.

12. Liu KC, Hamilton BE, Barnwell SL. Cerebral Venous and Sinus Thrombosis. In : Winn HR, editor. Youmans Neurological Surgery. ed 6. Philadelpia: Elsevier Saunders,;2011. 4:p. 3698–3705.

13. Lourenço Costa B, Shamasna M, Nunes J, Magalhães F, Peliz AJ. Cerebral venous thrombosis : an unexpected complication from spinal surgery. Eur Spine J. 2014; 23(Suppl 2):253–256. PMID: 24375330.

14. Martinelli I, Landi G, Merati G, Cella R, Tosetto A, Mannucci PM. Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb Haemost. 1996; 75:393–394. PMID: 8701395.

15. Pabinger I, Grafenhofer H, Kyrle PA, Quehenberger P, Mannhalter C, Lechner K, et al. Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism. Blood. 2002; 100:1060–1062. PMID: 12130523.

16. Ruíz-Sandoval JL, Cantú C, Barinagarrementeria F. Intracerebral hemorrhage in young people : analysis of risk factors, location, causes, and prognosis. Stroke. 1999; 30:537–541. PMID: 10066848.

17. Sanders MD, Hoyt WF. Hypoxic ocular sequelae of carotid-cavernous fistulae. Study of the caues of visual failure before and after neurosurgical treatment in a series of 25 cases. Br J Ophthalmol. 1969; 53:82–97. PMID: 5773469.

18. Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, et al. Diagnosis and management of cerebral venous thrombosis : a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42:1158–1192. PMID: 21293023.

19. Singleton RH, Jankowitz BT, Wecht DA, Gardner PA. Iatrogenic cerebral venous sinus occlusion with flowable topical hemostatic matrix. J Neurosurg. 2011; 115:576–583. PMID: 21456896.

20. Stam J. Cerebral venous and sinus thrombosis : incidence and causes. Adv Neurol. 2003; 92:225–232. PMID: 12760187.

21. United Nations. Department of Economic and Social Affairs. Population Division. World Contraceptive Use 2011. New York: United Nations. Department of Economic and Social Affairs. Population Division;2014.

22. United Nations Statistics Division. Crude Birth Rate. New York: United Nations Statistics Division;2014.

23. United Nations Statistics Division. Total Fertillity Rate. New York: United Nations Statistics Division;2014.